An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice

被引:1
作者
Yamazaki, Yuichi [1 ]
Yoshida, Yuka [2 ]
Shimizu, Megumi [1 ]
Kobayashi, Takeshi [1 ]
Tojima, Hiroki [1 ]
Sato, Ken [1 ]
Kakizaki, Satoru [1 ,3 ]
Handa, Hiroshi [4 ]
Yokoo, Hideaki [2 ]
Uraoka, Toshio [1 ]
机构
[1] Gunma Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Maebashi, Gumma, Japan
[2] Gunma Univ, Dept Human Pathol, Grad Sch Med, Maebashi, Gumma, Japan
[3] Natl Hosp Org Takasaki Gen Med Ctr, Dept Clin Res, Takasaki, Gumma, Japan
[4] Gunma Univ, Dept Hematol, Grad Sch Med, Maebashi, Gumma, Japan
关键词
autopsy; multicentric Castleman disease; severe jaundice; interleukin-6; LYMPH-NODE HYPERPLASIA; INTERLEUKIN-6;
D O I
10.2169/internalmedicine.6835-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 70-year-old man with multicentric Castleman disease (MCD) was admitted to our hospital with jaundice and ascites. Elevations in his bilirubin and interleukin-6 levels were noted, and computed tomography revealed hepatic atrophy and portal vein and bile duct disorders. Steroid therapy was started for MCD, but he died of hepatic failure. An autopsy revealed that the MCD activity was mild, but advanced fibrosis and cholestasis were observed in the liver. Mild infiltration of interleukin-6-positive plasma cells was noted in the highly fibrotic area of the liver. Although rare, liver and biliary tract damage may be also considered organ disorders of MCD.
引用
收藏
页码:3615 / 3620
页数:6
相关论文
共 50 条
  • [1] Multicentric Castleman disease mimicking IgG4-related disease: A case report
    Izumi, Yasumori
    Takeshita, Hayato
    Moriwaki, Yuji
    Hisatomi, Keiko
    Matsuda, Masakazu
    Yamashita, Natsuki
    Kawahara, Chieko
    Shigemitsu, Yoshika
    Iwanaga, Nozomi
    Kawakami, Atsushi
    Kurohama, Hirokazu
    Niino, Daisuke
    Ito, Masahiro
    Migita, Kiyoshi
    MODERN RHEUMATOLOGY, 2017, 27 (01) : 174 - 177
  • [2] Kidney Involvement in Multicentric Castleman Disease
    Suneja, Sumeet
    Chidambaram, Mala
    Herzenberg, Andrew M.
    Bargman, Joanne M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (03) : 550 - 554
  • [3] Bone marrow manifestations in multicentric Castleman disease
    Ibrahim, Hazem A. H.
    Balachandran, Kirsty
    Bower, Mark
    Naresh, Kikkeri N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (06) : 923 - 929
  • [4] Updates on the diagnosis and management of multicentric Castleman disease
    Wu, Ya-Ju
    Su, Kuei-Ying
    TZU CHI MEDICAL JOURNAL, 2021, 33 (01): : 22 - 28
  • [5] Candidate biomarkers for idiopathic multicentric Castleman disease
    Sumiyoshi, Remi
    Koga, Tomohiro
    Kawakami, Atsushi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2022, 62 (02) : 85 - 90
  • [6] Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease
    Fajgenbaum, David C.
    Kurzrock, Razelle
    IMMUNOTHERAPY, 2016, 8 (01) : 17 - 26
  • [7] Multicentric Castleman disease and the evolution of the concept
    Zhou, Ting
    Wang, Hao-Wei
    Pittaluga, Stefania
    Jaffe, Elaine S.
    PATHOLOGICA, 2021, 113 (05) : 339 - 353
  • [8] Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
    Yamada, Yumi
    Ueno, Toshinori
    Irifuku, Taisuke
    Nakashima, Ayumu
    Doi, Shigehiro
    Ichinohe, Tatsuo
    Masaki, Takao
    CLINICAL NEPHROLOGY, 2018, 90 (03) : 232 - 236
  • [9] MULTICENTRIC PLASMA CELL VARIANT CASTLEMAN'S DISEASE PRESENTING WITH CUTANEOUS VASCULITIS AND PULMONARY PARENCHYMAL INVOLVEMENT IN A PATIENT WITH ANKYLOSING SPONDYLITIS: CASE REPORT AND REVIEW OF THE LITERATURE
    Wolf, M.
    Van Offel, J. F.
    Van de Velde, A.
    Stevens, W. J. M. K.
    De Clerck, L. S.
    ACTA CLINICA BELGICA, 2011, 66 (04) : 305 - 310
  • [10] Unicentric castleman disease is not clearly distinguished from multicentric type: a case report
    Choi, Jeoung Ho
    Jo, Yun Ju
    Gong, Soo Jung
    Hong, Boo Whan
    Lee, Ho Jung
    Son, Byoung Kwan
    Jun, Dae Won
    Kim, Seong Hwan
    Park, Young Sook
    Seok, Ju Won
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (04) : 256 - 259